spacer
home > ict > Spring 2009
PUBLICATIONS

International Clinical Trials

ict
Spring 2009
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT.
   
Text
PDF
bullet
TRIAL MANAGEMENT
The effects of the recession and the prospect of thinning pipelines are major concerns for pharmaceutical companies; Sriram V of Frost & Sullivan discusses the long-term outlook for CROs.  
view
download pdf
Nicola Murgatroyd at Phlexglobal examines the importance of the role of clinical research associate and looks at the reasons why the industry is facing a shortage of candidates.  
view
download pdf
The increasing number of clinical trials being performed in developing economies has made high quality translation more important than ever, argues Mimi Maeda-Nye of TJC Global.  
view
download pdf
bullet
eCLINICAL
James Trammel at i3 Statprobe underlines the value of adaptive randomisation, explaining the methods that can be used to guarantee the validity of statistical conclusions.  
view
download pdf
In the context of the dramatic increase in the number of late-phase clinical trials worldwide, Kate Trainor of PAREXEL International looks at how the right technology can make a major difference in Phases IIIb and IV.  
view
download pdf
Tim Davis of Exco InTouch reflects on the immense popularity of SMS communication, and explains how text messaging technology can increase recruitment, retention and compliance in clinical trials  
view
download pdf
A well-integrated laboratory information management system, with the flexibility to work with an adaptive trial design, greatly increases the ability to get specimen handling, testing and reporting 'right first time', says Ed Krasovec of Starlims.  
view
download pdf
bullet
Regional trials
For clinical research conducted in developing countries, ethical concerns are a particularly salient issue. Harald Schmidt of the Nuffield Council of Bioethics and Peter G Smith of the London School of Hygiene & Tropical Medicine review the 2008 Declaration of Helsinki.  
view
download pdf
bullet
THERAPEUTICS
In light of the tough economic times, Richard N Williams of INC Research looks at how value can be maximised and drug development accelerated by embracing fresh regulatory initiatives.  
view
download pdf

Beata Paluchowska of Omnicare Clinical Research describes how the challenges involved in clinical trials for cancer drugs can be overcome by means of collaboration with oncology communities and experts from different fields.

 
view
download pdf
Jan Vertommon at Capsugel explains how enhanced bioavailability can improve the quality of data obtained from first-in-human clinical trials and evaluates the ways in which this can be achieved.  
view
download pdf
Nick Charles of Mayo Clinic presents a case study on the benefits of running a collaborative trial for Graves' ophthalmopathy.  
view
download pdf
bullet
Labs & Logistics
Jeffrey Litwin of ERT Inc looks at the critical role of central core labs in performing thorough ECG analysis.  
view
download pdf
Nick Townsend of LabWare explains why configurable LIMS with purpose-built modules are an asset for clinical trials, and looks at the options available when choosing a LIMS product.  
view
download pdf
As the focus of clinical trial activity shifts towards Asia, Robert Scott-Edwards of ICON Central Laboratories investigates the opportunities and challenges in India.  
view
download pdf
Geraint Thomas at Laminar Medica outlines the factors to consider when developing a passives cooling system which offers protection while meeting all relevant laws, regulations and guidelines.  
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August, and November

News and Press Releases

Protagen Protein Services (PPS) reaches new level in characterizing HCP protein impurities

In response to current regulatory guidance a Mass Spectrometry (MS) based Host Cell Protein (HCP) detection approach with faster, more accurate and wider-ranging detection is essential. In order to meet the newly prevailing demands Protagen Protein Services (PPS) recently invested in more far-reaching MS capabilities: The new high-performing mass spectrometer ThermoFisher Q Exactive™ HF-X started operational service last month and brings PPS to the next level of reproducible, accurate and sensitive analyses of majorly complex samples for different aspects of translational research and biopharma applications.
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

Industry Events

SMi Presents the 11th Adaptive Designs in Clinical Trials Conference 2019

1-2 April 2019, Holiday Inn Kensington Forum, London

SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials - demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement